Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia
Colleen M Craig, Li-Fen Liu,
Carolyn F Deacon
,
Jens J Holst
, Tracey L McLaughlin
Endocrinology and Metabolism
59
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Glucagon-like
100%
Post-bariatric Hypoglycemia
100%
Non-surgical
42%
Exendin (9-39)
42%
Surgical Control
42%
Glucagon-like peptide-1 Receptor (GLP-1R)
28%
Hypoglycemia
28%
OGTT
28%
β-cell Function
14%
Postprandial Insulin
14%
Clinical Research
14%
Metabolic
14%
Time to Peak
14%
Pharmacokinetics
14%
Therapeutic Strategies
14%
Stanford University
14%
Trial Registration
14%
Asymptomatic Hypoglycemia
14%
Autonomic Symptoms
14%
Competitive Antagonism
14%
Insulin Secretion
14%
A1 Receptor
14%
Secretion Rate
14%
Placebo
14%
Translational Research
14%
Bariatric Surgery
14%
Receptor Blockade
14%
Receptor Antagonist
14%
Hyperinsulinemic Hypoglycemia
14%
Intravenous Infusion
14%
Relative Contribution
14%
Insulin Concentration
14%
Dysregulated
14%
Incretin Hormones
14%
Insulin
14%
Metabolic Disorders
14%
Hormone Signaling
14%
Associated Symptoms
14%
Medicine and Dentistry
Hypoglycemia
100%
Obesity Medicine
100%
Glucagon Like Peptide 1
100%
Glucagon Like Peptide 1 Receptor
30%
Exendin 9
30%
Infusion
20%
Oral Glucose Tolerance Test
20%
Hyperinsulinemic Hypoglycemia
10%
Pharmacokinetic
10%
Receptor Blocking
10%
Translational Research
10%
Water-Electrolyte Imbalance
10%
Body Mass Index
10%
Bariatric Surgery
10%
Cell Function
10%
Insulin Release
10%
Placebo
10%
Beta Cell
10%
Hormone Signaling
10%
Intravenous Drug Administration
10%
Incretin
10%
Competitive Inhibition
10%
Clinical Research
10%
Secretion (Process)
10%
Receptor Antagonist
10%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide 1 Receptor
100%
Glucagon-Like Peptide-1
100%
Receptor Antagonist
33%
Insulin Release
33%
Metabolic Disorder
33%
Cell Function
33%
Incretin
33%
Pharmacokinetic
33%
Competitive Inhibition
33%
Receptor Blocking
33%
Secretion (Process)
33%
Agricultural and Biological Sciences
Glucagon-Like Peptide-1
100%
Glucagon-Like Peptide 1 Receptor
100%
Insulin Secretion
33%
Pharmacokinetic
33%
Placebo
33%
Cross-over Studies
33%
Incretin
33%
Body Mass Index
33%
Beta Cell
33%
Neuroscience
Hypoglycemia
100%
Glucagon-Like Peptide-1
100%
Glucagon-Like Peptide 1 Receptor
30%
Exendin 9
30%
Incretin
10%
Cell Function
10%
Crossover Study
10%
Pharmacokinetic
10%
Placebo
10%
Metabolic Disorder
10%
Receptor Antagonist
10%
Competitive Inhibition
10%
Body Mass Index
10%
Beta Cell
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
100%
Glucagon-Like Peptide-1
100%
Glucagon-Like Peptide 1 Receptor
27%
Exendin 9
27%
Metabolic Disorder
9%
Receptor Antagonist
9%
Placebo
9%
Incretin
9%
Pharmacokinetic
9%